Related references
Note: Only part of the references are listed.MicroRNA-29b mediates altered innate immune development in acute leukemia
Bethany L. Mundy-Bosse et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
O3.2 * Phase I and dose ranging, phase II studies with IPH2201, a humanized monoclonal antibody targeting HLA-E receptor CD94/NKG2A
L. Seymour et al.
ANNALS OF ONCOLOGY (2015)
Reconstitution of Natural Killer Cells in HLA-Matched HSCT after Reduced-Intensity Conditioning: Impact on Clinical Outcome
Caroline Pical-Izard et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Defective NK Cells in Acute Myeloid Leukemia Patients at Diagnosis Are Associated with Blast Transcriptional Signatures of Immune Evasion
Zena Khaznadar et al.
JOURNAL OF IMMUNOLOGY (2015)
Increased NK cell maturation in patients with acute myeloid leukemia
Anne-Sophie Chretien et al.
FRONTIERS IN IMMUNOLOGY (2015)
CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targets
Michelle K. Gleason et al.
BLOOD (2014)
Acute myeloid leukemia impairs natural killer cells through the formation of a deficient cytotoxic immunological synapse
Zena Khaznadar et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
Leukemia-induced phenotypic and functional defects in natural killer cells predict failure to achieve remission in acute myeloid leukemia
Kate Stringaris et al.
HAEMATOLOGICA (2014)
Impaired NK cells and increased T regulatory cell numbers during cytotoxic maintenance therapy in AML
Felix S. Lichtenegger et al.
LEUKEMIA RESEARCH (2014)
Cancer-inducecd alterations of NK-mediated target recognition: current and investigational pharmacological strategies aiming at restoring NK-mediated anti-tumor activity
Anne-Sophie Chretien et al.
FRONTIERS IN IMMUNOLOGY (2014)
Peripheral Blood NK Cells from Breast Cancer Patients Are Tumor-Induced Composite Subsets
Emilie Mamessier et al.
JOURNAL OF IMMUNOLOGY (2013)
Natural killer cells modulation in hematological malignancies
Celine Baier et al.
FRONTIERS IN IMMUNOLOGY (2013)
The role of natural killer cells in hematopoietic stem cell transplantation
Panagiotis D. Tsirigotis et al.
ANNALS OF MEDICINE (2012)
A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission
Norbert Vey et al.
BLOOD (2012)
Pre-eminence and persistence of immature natural killer cells in acute myeloid leukemia patients in first complete remission
Nicolas Dauguet et al.
AMERICAN JOURNAL OF HEMATOLOGY (2011)
NK cell education after allogeneic transplantation: dissociation between recovery of cytokine-producing and cytotoxic functions
Bree Foley et al.
BLOOD (2011)
Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity
Emilie Mamessier et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
CD56brightCD16+ NK Cells: A Functional Intermediate Stage of NK Cell Differentiation
Vivien Beziat et al.
JOURNAL OF IMMUNOLOGY (2011)
Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors
Nicolas F. Delahaye et al.
NATURE MEDICINE (2011)
Regulation of human NK-cell cytokine and chemokine production by target cell recognition
Cyril Fauriat et al.
BLOOD (2010)
Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education
Niklas K. Bjorkstrom et al.
BLOOD (2010)
CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset
Sandra Lopez-Verges et al.
BLOOD (2010)
Peripheral blood T cells in acute myeloid leukemia (AML) patients at diagnosis have abnormal phenotype and genotype and form defective immune synapses with AML blasts
Rifca Le Dieu et al.
BLOOD (2009)
An unusual CD56bright CD16low NK cell subset dominates the early posttransplant period following HLA-matched hematopoietic stem cell transplantation
Nicolas Dulphy et al.
JOURNAL OF IMMUNOLOGY (2008)
Effect of frequently used chemotherapeutic drugs on cytotoxic activity of human cytotoxic T-lymphocytes
Laszlo Markasz et al.
JOURNAL OF IMMUNOTHERAPY (2008)
The CD16-CD56bright NK cell subset is resistant to reactive oxygen species produced by activated Granulocytes and has higher antioxidative capacity than the CD16+CD56dim subset
Helena Harlin et al.
JOURNAL OF IMMUNOLOGY (2007)
Effect of frequently used chemotherapeutic drugs on the cytotoxic activity of human natural killer cells
Laszlo Markasz et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Deficient expression of NCR in NK cells from acute myeloid leukemia: evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction
Cyril Fauriat et al.
BLOOD (2007)
Activation, coactivation, and costimulation of resting human natural killer cells
Yenan T. Bryceson et al.
IMMUNOLOGICAL REVIEWS (2006)
Tumor growth impedes natural-killer-cell maturation in the bone marrow
John O. Richards et al.
BLOOD (2006)
Improved leukemia-free survival after postconsolidation immunotherapy with histamine dihydrochloride and interleukin-2 in acute myeloid leukemia: results of a randomized phase 3 trial
Mats Brune et al.
BLOOD (2006)
Immunologic approaches to acute leukemia in the elderly
SS Farag et al.
SEMINARS IN HEMATOLOGY (2006)
NKp46 and NKG2D receptor expression in NK cells with CD56(dim) and CD56(bright) phenotype: regulation by histamine and reactive oxygen species
AI Romero et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer
JS Miller et al.
BLOOD (2005)
Immunobiology of haematological malignant disorders: the basis for novel immunotherapy protocols
RT Costello et al.
LANCET ONCOLOGY (2004)
NK cells: innate immunity against hematological malignancies?
RT Costello et al.
TRENDS IN IMMUNOLOGY (2004)
Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia
RT Costello et al.
BLOOD (2002)
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
L Ruggeri et al.
SCIENCE (2002)
Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population
K Imai et al.
LANCET (2000)
Share Paper
